|View printer-friendly version|
|January 29, 2002 4:07 p.m.|
|Teva Announces Final Approval for Fluoxetine 10, 20 & 40 mg Capsules|
Jerusalem, Israel, January 29, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has granted final approval for Fluoxetine 10, 20 and 40 mg capsules and for Fluoxetine 10 mg tablets. Teva now has approval for all Fluoxetine dosages, and will launch these new forms immediately.